Lynne McGrath
Directeur/Bestuurslid bij ALZAMEND NEURO, INC.
Vermogen: 3 500 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Lynne McGrath
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
26
| Subsidiary | Pharmaceuticals: Major | 26 |
Public Company | Pharmaceuticals: Major | 19 | |
Public Company | Pharmaceuticals: Major | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Lynne McGrath via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Human Resources Officer Corporate Officer/Principal President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AULT ALLIANCE, INC. | Electrical Products | Director of Finance/CFO Chairman Chief Executive Officer President Corporate Officer/Principal General Counsel | |
AULT DISRUPTIVE TECHNOLOGIES CORPORATION | Financial Conglomerates | Director/Board Member Director of Finance/CFO Chairman Chief Executive Officer President Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
THE SINGING MACHINE COMPANY, INC. | Movies/Entertainment | Director/Board Member Chairman Director/Board Member Director/Board Member | |
AVALANCHE INTERNATIONAL, CORP. | Industrial Machinery | Chairman Director of Finance/CFO General Counsel General Counsel | |
University of Maryland | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
CELGENE | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Ault & Co., Inc.
Ault & Co., Inc. Financial ConglomeratesFinance Ault & Co., Inc. operates as a holding company which acquires undervalued assets and disruptive technologies. Its operating companies includes technology, commercial, defense, aerospace, industrial, health bio-tech, hospitality, real estate. The company is headquartered in Newport Beach, CA. | Financial Conglomerates | Chairman Director of Finance/CFO President | |
Ault Life Sciences, Inc.
Ault Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ault Life Sciences, Inc. holds securities in other pharmaceutical company. It also intends acquire equity positions in additional life science companies. The company was founded by Milton C. Ault III in 2020 and is headquartered in Newport Beach, CA. | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO President | |
RISKON INTERNATIONAL, INC. | Gas Distributors | Chairman Director/Board Member President | |
INCYTE CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Stanford University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Tech/Sci/R&D Officer Chairman Chief Operating Officer | |
Robert H. Smith School of Business | College/University | Graduate Degree Masters Business Admin | |
AXCA HEALPAR | Biotechnology | Chairman Chief Executive Officer | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
The University of Chicago | College/University | Masters Business Admin Doctorate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
GSK PLC | Pharmaceuticals: Major | Private Equity Analyst Corporate Officer/Principal | |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member President | |
SPEXIS AG | Pharmaceuticals: Major | Chairman Director/Board Member | |
FOXKISER LLP
FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services FOXKISER LLP engages in the provision of strategic advice and counseling services to pharmaceutical and biotechnology companies. Its project works fall into three general categories: advisory services; long-term partnerships; and new company formation. The company was founded by John Daniel Kiser and Allan M. Fox in September 1986 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Founder | |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
University of Massachusetts | College/University | Director/Board Member Undergraduate Degree | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
TURNONGREEN, INC | Electrical Products | Chief Executive Officer Director of Finance/CFO | |
Microphase Corp.
Microphase Corp. Telecommunications EquipmentElectronic Technology Microphase Corp. engages in the design, development, and manufacture of standard and customized radio frequency, microwave, and millimeter-wave components, devices, subsystems and integrated modules. It products include detectors, limiters, multipliers, switches, couplers; DLVAs/SDLVAs; filter products; multifunction assemblies and integrated subsystems; millimeter wave products; amplifiers; CATV/wireline products; and teset and measurement products. The company was founded by Necdet F. Ergul in 1955 and is headquartered in Shelton, CT. | Telecommunications Equipment | Director/Board Member Director/Board Member | |
CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ault Glazer Bodnar Securities LLC
Ault Glazer Bodnar Securities LLC Investment Banks/BrokersFinance Part of Tytan Holdings, Inc., Ault Glazer Bodnar Securities LLC provides investment banking services. The company is based in Los Angeles, CA. Milton Charles Ault has been the CEO of the company since 2005. | Investment Banks/Brokers | Chief Executive Officer Director of Finance/CFO | |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
Verenigde Staten | 42 |
Zwitserland | 6 |
Verenigd Koninkrijk | 2 |
Frankrijk | 2 |
Noorwegen | 2 |
Sectoraal
Health Technology | 26 |
Consumer Services | 9 |
Commercial Services | 8 |
Producer Manufacturing | 4 |
Finance | 4 |
Operationeel
Director/Board Member | 270 |
Corporate Officer/Principal | 161 |
Independent Dir/Board Member | 85 |
Chairman | 67 |
Chief Executive Officer | 55 |
Sterkste connecties
Insiders | |
---|---|
Argeris Karabelas | 42 |
George Golumbeski | 36 |
Camille Samuels | 30 |
David Epstein | 29 |
Edgar Engleman | 29 |
Todd Ault | 27 |
Mark Gustafson | 24 |
Helen Boudreau | 22 |
Kenneth Cragun | 22 |
Benjamin Auspitz | 20 |
Luke Beshar | 19 |
William Horne | 17 |
Steven Baert | 16 |
Daniel Tassé | 16 |
Olivier Danos | 15 |
- Beurs
- Insiders
- Lynne McGrath
- Bedrijfsconnecties